C. Luley

C. Luley, K. Bosselmann, J. Dierkes, 2001, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Extended-release niacin raises adiponectin and leptin.

K. Borucki, R. Makarova, C. Luley, 2007, Atherosclerosis.

Cardiac Troponin T Predicts Mortality in Patients With End-Stage Renal Disease

C. Luley, S. Westphal, J. Dierkes, 2000, Circulation.

Chylomicron remnants of various sizes are lowered more effectively by fenofibrate than by atorvastatin in patients with combined hyperlipidemia.

L. Wiens, C. Luley, S. Westphal, 2003, Atherosclerosis.

Point-of-care testing of triglycerides: evaluation of the Accutrend triglycerides system.

R. Heine, G. King, S. Bakker, 2000, Clinical chemistry.

An improved method for the rapid assessment of persisting chylomicron remnant concentrations.

C. Luley, S. Westphal, M. Orth, 2001, Clinical biochemistry.

Endothelial dysfunction induced by postprandial lipemia is neutralized by addition of proteins to the fatty meal.

S. Kropf, Elina Taneva, C. Luley, 2006, Atherosclerosis.

Flavanol-rich cocoa ameliorates lipemia-induced endothelial dysfunction

C. Luley, S. Westphal, 2011, Heart and Vessels.

Preliminary report Adipokines and treatment with niacin

K. Borucki, R. Makarova, C. Luley, 2006 .

Adipokines and treatment with niacin.

K. Borucki, R. Makarova, C. Luley, 2006, Metabolism: clinical and experimental.

Platelet count and platelet activation: Impact of a fat meal and day time

L. Wiens, C. Luley, S. Westphal, 2007, Platelets.

Preferential increase in high-molecular weight adiponectin after niacin.

C. Luley, S. Westphal, 2008, Atherosclerosis.

Testosterone Lowers Serum Concentrations of Lipoprotein Lp(a)

J. Keul, A. Berg, M. Baumstark, 1993 .

Haplotypes in the UGT1A1 gene and their role as genetic determinants of bilirubin concentration in healthy German volunteers.

E. Fisher, C. Weikert, K. Borucki, 2009, Clinical biochemistry.

Compositional and functional changes of low-density lipoprotein during hemodialysis in patients with ESRD.

C. Luley, S. Westphal, J. Dierkes, 1998, Kidney international.

Antihypertensive treatment and homocysteine concentrations.

C. Luley, S. Westphal, J. Dierkes, 2003, Metabolism: clinical and experimental.

Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial.

C. Luley, S. Westphal, M. Deuschle, 2011, The Journal of clinical psychiatry.

Post-hoc analysis on the CD14 C(-260)T promoter polymorphism and coronary heart disease.

G. Schmitz, C. Luley, S. Westphal, 2007, Physiological research.

Lipid Metabolism and Insulin Resistance in Depressed Patients: Significance of Weight, Hypercortisolism, and Antidepressant Treatment

I. Heuser, H. Lehnert, C. Luley, 2004 .

Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.

I. Heuser, H. Lehnert, C. Luley, 2004, Journal of clinical psychopharmacology.

Supplementation with vitamin B12 decreases homocysteine and methylmalonic acid but also serum folate in patients with end-stage renal disease.

C. Luley, A. Guttormsen, J. Dierkes, 1999, Metabolism: clinical and experimental.

Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate.

C. Luley, S. Westphal, J. Dierkes, 2001, Atherosclerosis.

Weight Loss and Changes in Salivary Ghrelin and Adiponectin: Comparison Between Sleeve Gastrectomy and Roux-en-Y Gastric Bypass and Gastric Banding

H. Lippert, C. Luley, S. Westphal, 2011, Obesity surgery.

Plasma folate as marker of folate status in epidemiological studies: the European Investigation into Cancer and Nutrition (EPIC)-Potsdam study

H. Boeing, K. Klipstein‐Grobusch, C. Luley, 2004, British Journal of Nutrition.

Treatment with niacin lowers ADMA.

K. Borucki, C. Luley, S. Westphal, 2006, Atherosclerosis.

Effects of fenofibrate and gemfibrozil on plasma homocysteine

C. Luley, S. Westphal, J. Dierkes, 2001, The Lancet.

Comparison of Serum and Salivary Ghrelin in Healthy Adults, Morbidly Obese, and Patients with Metastatic Carcinoma

H. Lippert, C. Luley, S. Westphal, 2011, Obesity surgery.

Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patients.

C. Luley, S. Westphal, U. Tröger, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Addition of 2.5 g L-arginine in a fatty meal prevents the lipemia-induced endothelial dysfunction in healthy volunteers.

K. Borucki, C. Luley, S. Westphal, 2009, Atherosclerosis.

Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.

C. Luley, J. Dierkes, A. Ambrosch, 1999, Clinical nephrology.

Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.

J. Heinz, S. Kropf, C. Luley, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Detection of recent ethanol intake with new markers: comparison of fatty acid ethyl esters in serum and of ethyl glucuronide and the ratio of 5-hydroxytryptophol to 5-hydroxyindole acetic acid in urine.

F. Wurst, K. Borucki, C. Luley, 2005, Alcoholism, clinical and experimental research.

Gene expression profile of CD14+ blood monocytes following lifestyle-induced weight loss in individuals with metabolic syndrome

J. Schneider, K. Roomp, B. Isermann, 2020, Scientific Reports.

Serum bile acids and GLP-1 decrease following telemetric induced weight loss: results of a randomized controlled trial

J. Schneider, B. Isermann, C. Weikert, 2016, Scientific Reports.

Postprandial lipid and carbohydrate responses after the ingestion of a casein-enriched mixed meal.

A. Leodolter, Elina Taneva, C. Luley, 2004, The American journal of clinical nutrition.

Plasma pyridoxal-5-phosphate and future risk of myocardial infarction in the European Prospective Investigation into Cancer and Nutrition Potsdam cohort.

H. Boeing, K. Klipstein‐Grobusch, C. Weikert, 2007, The American journal of clinical nutrition.

Measurement of low apolipoprotein concentrations by optimized immunoturbidimetric applications.

C. Luley, S. Westphal, M. Porsch-Ozcürümez, 2001, Clinical chemistry.

A free fatty acid tolerance test identifies patients with coronary artery disease among individuals with a low conventional coronary risk profile

H. Wieland, C. Luley, S. Westphal, 2002, Heart and Vessels.

Fenofibrate-Induced Hyperhomocysteinaemia

C. Luley, S. Westphal, J. Dierkes, 2003, Drug safety.

Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels

C. Luley, S. Westphal, J. Dierkes, 2007, Vascular health and risk management.

B Vitamins and the Risk of Total Mortality and Cardiovascular Disease in End-Stage Renal Disease: Results of a Randomized Controlled Trial

J. Heinz, S. Kropf, K. Borucki, 2010, Circulation.

In heavy drinkers fatty acid ethyl esters in the serum are increased for 44 hr after ethanol consumption.

B. Bogerts, K. Borucki, C. Luley, 2004, Alcoholism, clinical and experimental research.

In heavy drinkers, fatty acid ethyl esters remain elevated for up to 99 hours.

K. Borucki, C. Luley, S. Westphal, 2007, Alcoholism, clinical and experimental research.

No significant effect of acute moderate alcohol intake on leptin levels in healthy male volunteers

F. Wurst, T. Schulte, G. Dammann, 2005, Addiction biology.

Endocrine and behavioural plasticity in response to juvenile stress in the semi-precocial rodent Octodon degus

K. Braun, C. Luley, S. Westphal, 2006, Psychoneuroendocrinology.

Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study.

H. Boeing, C. Luley, S. Westphal, 2001, Metabolism: clinical and experimental.

Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial.

C. Luley, A. Olsson, G. Broda, 2001, Clinical therapeutics.

Determination of asymmetric dimethylarginine: liquid chromatography-mass spectrometry or ELISA?

C. Luley, S. Westphal, F. Awiszus, 2005, Clinical chemistry.

Within-subject variation of plasma resistin levels over a 1-year period

S. Willich, T. Pischon, H. Boeing, 2007, Clinical chemistry and laboratory medicine.

Weight Loss by Telemonitoring of Nutrition and Physical Activity in Patients with Metabolic Syndrome for 1 Year

Siegfried Kropf, Sabine Westphal, Florian Kicherer, 2014, Journal of the American College of Nutrition.

Addition of glucose to a fatty meal delays chylomicrons and suppresses VLDL in healthy subjects

P. Malfertheiner, A. Leodolter, C. Luley, 2002, European journal of clinical investigation.

Evaluation of Three New Strategies to Fight Obesity in Families

S. Kropf, C. Luley, S. Westphal, 2010, Journal of nutrition and metabolism.

Long-Term Follow-Up of the Telemonitoring Weight-Reduction Program “Active Body Control”

S. Kropf, C. Luley, S. Westphal, 2016, Journal of diabetes research.

3.P.126 Anticoagulation with heparin during hemodialysis causes prenounced LDL alterations

C. Luley, S. Westphal, A. Ambrosch, 1997 .

Analysis of the Transcobalamin II 776C>G (259P>R) Single Nucleotide Polymorphism by Denaturing HPLC in Healthy Elderly: Associations with Cobalamin, Homocysteine and Holo-Transcobalamin II

C. Luley, J. Dierkes, S. Jakubiczka, 2003, Clinical Chemistry and Laboratory Medicine.

Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus

H. Lehnert, C. Luley, J. Dierkes, 2001, Diabetic medicine : a journal of the British Diabetic Association.

Decreased progesterone binding and attenuated progesterone action in cultured human breast carcinoma cells treated with epidermal growth factor.

W. Blattner, J. Nadeau, C. Pui, 1988, Cancer research.

The Diagnostic Value of Serum Homocysteine Concentration as a Risk Factor for Coronary Artery Disease

H. Wieland, C. Luley, M. Orth, 1998, Clinical chemistry and laboratory medicine.

Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease.

C. Luley, D. Kunz, H. Kloer, 1999, Journal of the American College of Cardiology.

Effects of a frequent apolipoprotein E isoform, ApoE4Freiburg (Leu28-->Pro), on lipoproteins and the prevalence of coronary artery disease in whites.

R. Mahley, G. Assmann, K. Weisgraber, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Vitamins and the Risk of Total Mortality and Cardiovascular Disease in End-Stage Renal Disease

J. Heinz, S. Kropf, K. Borucki, 2010 .

Influence of a supplementation with vitamins on cardiovascular morbidity and mortality in patients with end-stage renal disease: design and baseline data of a randomized clinical trial.

J. Heinz, S. Kropf, C. Luley, 2009, Clinical nephrology.

Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids.

C. Luley, S. Westphal, M. Orth, 2000, The American journal of clinical nutrition.

Terminal differentiation and growth inhibition of a rat rhabdomyosarcoma cell line (BA-HAN-1C) in vitro after exposure to retinoic acid.

C. Gerharz, H. Gabbert, C. Luley, 1988, Cancer research.